Consistent with previous studies16,35, a large number of BRAFi-resistant colonies emerged in cultures of parental melanoma cells treated with the BRAFi alone, which was significantly reduced in cultures concomitantly treated with AR inhibitors (Fig. 8e). This evidence concerns the gene AR and melanoma.